๐ฐ Roivant Sciences News
Page 28 - Roivant Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Roivant Sciences. Real-time updates on events, politics, business and more.
September 28, 2023
As the 2024 presidential debates are underway, a look at how the polls rate the candidates is in order.
September 28, 2023
The seven candidates intensified their attacks against the former president, who is leading the race for the 2024 nomination by more than 40 points
September 28, 2023
Vivek Ramaswamy, the son of Indian immigrants, resurrected a 2015 proposal of ending birthright citizenship from then-candidate Donald Trump. Continuing his proposals of harsh policy changes, Indian
September 27, 2023
Keybanc cut the price target for Danaher Corporation (NYSE: DHR) from $325 to $300. Keybanc analyst Paul Knight maintained an Overweight rating. Danaher shares rose 0.6% to $248.75 in pre-market trading.
September 27, 2023
Analysis of Vivek Ramaswamy's proposals to dramatically overhaul the H-1B visa program for high-skilled foreign workers. Assessing impact on tech talent, wages, jobs, innovation.
September 27, 2023
A lifelong fixation on returns made Vivek Ramaswamy a billionaire by 38. Win or lose in 2024, hell emerge richer and more influential than everโjust how he planned it.
September 27, 2023
Senate advances short-term spending bill; Stocks slide; Exclusive with Mark Zuckerberg; TikTok monitoring concerns; Judge rules Trump committed fraud; and more
September 27, 2023
Planning to watch the second Republican debate of the 2024 presidential race? Here's everything to know.
September 27, 2023
Who is Vivek Ramaswamy, Republican US presidential hopeful?
September 27, 2023
The company may have best-in-class autoimmune disease therapy under its roof.